World's Best Scientists 2026 revealed!
VIEW LIST
Florence I. Raynaud

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 77 1116 995 88 79 363 19713

Florence I. Raynaud publications per year

The chart shows the history of publications by Florence I. Raynaud between 1973 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Florence I. Raynaud published across 53 years, from 1973 to 2025, averaging 14.4 papers a year. Output peaked at 331 publications in 2023. 27 of the 765 publications appeared in the last two years.

No. of publications
100 200 300
Bar chart. Horizontal axis: year, 1973 to 2025. Vertical axis: number of publications, 0 to 331. Peak 331 publications in 2023. 1973: 1 publication 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 0 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 1 publication 1983: 0 publications 1984: 3 publications 1985: 3 publications 1986: 3 publications 1987: 3 publications 1988: 5 publications 1989: 6 publications 1990: 3 publications 1991: 8 publications 1992: 4 publications 1993: 6 publications 1994: 4 publications 1995: 6 publications 1996: 10 publications 1997: 10 publications 1998: 10 publications 1999: 3 publications 2000: 2 publications 2001: 2 publications 2002: 5 publications 2003: 5 publications 2004: 10 publications 2005: 13 publications 2006: 7 publications 2007: 26 publications 2008: 18 publications 2009: 9 publications 2010: 21 publications 2011: 20 publications 2012: 19 publications 2013: 17 publications 2014: 10 publications 2015: 15 publications 2016: 27 publications 2017: 22 publications 2018: 13 publications 2019: 15 publications 2020: 17 publications 2021: 13 publications 2022: 12 publications 2023: 331 publications 2024: 9 publications 2025: 18 publications
1973 2025

765 publications in total across all disciplines

View publications per year as a table
Florence I. Raynaud: publications per year, 1973 to 2025
Year Publications
1973 1
1974 0
1975 0
1976 0
1977 0
1978 0
1979 0
1980 0
1981 0
1982 1
1983 0
1984 3
1985 3
1986 3
1987 3
1988 5
1989 6
1990 3
1991 8
1992 4
1993 6
1994 4
1995 6
1996 10
1997 10
1998 10
1999 3
2000 2
2001 2
2002 5
2003 5
2004 10
2005 13
2006 7
2007 26
2008 18
2009 9
2010 21
2011 20
2012 19
2013 17
2014 10
2015 15
2016 27
2017 22
2018 13
2019 15
2020 17
2021 13
2022 12
2023 331
2024 9
2025 18
Total 765
Download as CSV

Florence I. Raynaud publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Florence I. Raynaud sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 357–366 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 363 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29 363
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Florence I. Raynaud D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Florence I. Raynaud sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 76–77 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 77 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Florence I. Raynaud is affiliated with the Institute of Cancer Research in the United Kingdom and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research activity spans molecular biology, oncology, pulmonary and respiratory medicine, genetics, and cancer research. The scientist's work is characterized by a focus on protein degradation and inhibitors, CAR-T cell therapy research, ubiquitin and proteasome pathways, prostate cancer treatment and research, glioma diagnosis and treatment, metabolomics and mass spectrometry studies, and heat shock proteins research.

Recent research papers authored or co-authored by this scientist include:

  • Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non- BRCA1/2-Mutant Cancers, 2020, Cancer Discovery
  • Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance, 2023, Nature
  • A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer, 2020, Annals of Oncology
  • Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders, 2020, Journal of Medicinal Chemistry
  • Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers, 2020, Cancer Discovery

Frequent co-authors include:

  • Angela Hayes
  • Ruth Ruddle
  • Rosemary Burke
  • Udai Banerji
  • Olivier A. Pierrat

The scientist often publishes in a variety of journals and venues, with multiple publications appearing in:

  • Journal of Medicinal Chemistry
  • Cancer Research
  • Neuro-Oncology
  • Clinical Cancer Research
  • Nature Communications

Florence I. Raynaud's body of work engages primarily with studies related to molecular biology and oncology, which aligns with their active research contributions in cancer discovery and therapeutic approaches.

Best Publications

  • The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†

    Adrian J. Folkes;Khatereh Ahmadi;Wendy K. Alderton;Sonia Alix

  • Effect of sleep deprivation on the human metabolome.

    Sarah K. Davies;Joo Ern Ang;Victoria L. Revell;Ben Holmes

  • NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis

    Suzanne A Eccles;Andy Massey;Florence I Raynaud;Swee Y Sharp

  • 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

    Paul A. Brough;Wynne Aherne;Xavier Barril;Jenifer Borgognoni

  • Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

    Florence I. Raynaud;Suzanne Eccles;Paul A. Clarke;Angela Hayes

  • Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy

    Charles J. Ryan;Matthew R. Smith;Lawrence Fong;Jonathan E. Rosenberg

  • Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

    Paul Workman;Paul A. Clarke;Florence I. Raynaud;Rob L.M. van Montfort

  • Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

    Florence I. Raynaud;Suzanne A. Eccles;Sonal Patel;Sonia Alix

  • Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.

    Lindsay Stimson;Martin G. Rowlands;Yvette M. Newbatt;Nicola F. Smith

  • Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.

    Udai Banerji;Michael Walton;Florence Raynaud;Rachel Grimshaw

  • Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth in Vitro and in Vivo

    Barbara A Spruce;Lorna A Campbell;Niall McTavish;Michelle A Cooper

  • Synthesis and biological evaluation of pyrido[3′,2′:4,5]furo[3,2- d ]pyrimidine derivatives as novel PI3 kinase p110α inhibitors

    Masahiko Hayakawa;Hiroyuki Kaizawa;Hiroyuki Moritomo;Tomonobu Koizumi

  • Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).

    J Holford;F Raynaud;B A Murrer;K Grimaldi

  • Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors.

    Masahiko Hayakawa;Hiroyuki Kaizawa;Ken-Ichi Kawaguchi;Noriko Ishikawa

  • Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

    Jane Renshaw;Kathryn R. Taylor;Ryan Bishop;Melanie Valenti

  • Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues

    Swee Y. Sharp;Chrisostomos Prodromou;Kathy Boxall;Marissa V. Powers

  • Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2 -a]pyridines as novel PI3 kinase p110α inhibitors

    Masahiko Hayakawa;Ken-Ichi Kawaguchi;Hiroyuki Kaizawa;Tomonobu Koizumi

  • In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

    Florence I Raynaud;Steven R Whittaker;Peter M Fischer;Steven McClue

  • Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

    S. J. Shuttleworth;F. A. Silva;A. R.L. Cecil;C. D. Tomassi

  • Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns.

    A S Moore;A Faisal;D Gonzalez de Castro;V Bavetsias

Frequent Co-Authors

Paul Workman
Paul Workman Institute of Cancer Research
Suzanne A. Eccles
Suzanne A. Eccles Institute of Cancer Research
Ian Judson
Ian Judson Institute of Cancer Research
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Ian Collins
Ian Collins PharmEnable Therapeutics
Lloyd R. Kelland
Lloyd R. Kelland University College London
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Chris Jones
Chris Jones Institute of Cancer Research
Paul Pévet
Paul Pévet University of Strasbourg
Martin O. Leach
Martin O. Leach Royal Marsden NHS Foundation Trust

External Links

Personal website of Florence I. Raynaud

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to a wide array of career paths beyond the lab. Many students branch out into counseling, psychology, and forensic science, which are all increasingly accessible through online programs.

For those interested in mental health support, you might consider enrolling in one of the fastest online counseling degree programs. These accelerated options can quickly prepare you for direct client work, helping populations in need.

If the intersection of biology and crime-solving intrigues you, learning how much does a forensic psychologist make can guide your decision. Forensic psychologists with a background in science are in demand for their expertise in both criminal justice and behavioral science.

Those passionate about developmental science should explore an online child psychology degree. These degrees focus on the psychological needs of young people and often complement a strong foundation in biology.

Finally, if you're seeking flexibility and affordability as you advance your career, there are many online master degree programs in counseling that can help you specialize in areas aligned with molecular biology, such as neurobiology or behavioral health.

Best Scientists Citing Florence I. Raynaud

Paul Workman

Paul Workman

Institute of Cancer Research

Publications: 132

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 94

Gerhardt Attard

Gerhardt Attard

University College London

Publications: 56

Ian Collins

Ian Collins

PharmEnable Therapeutics

Publications: 41

Howard I. Scher

Howard I. Scher

Memorial Sloan Kettering Cancer Center

Publications: 40

Stefan Knapp

Stefan Knapp

Goethe University Frankfurt

Publications: 35

Lori S. Friedman

Lori S. Friedman

Genentech

Publications: 32

Martin E. Gleave

Martin E. Gleave

University of British Columbia

Publications: 31

Martin O. Leach

Martin O. Leach

Royal Marsden NHS Foundation Trust

Publications: 29

Gabriela Chiosis

Gabriela Chiosis

Memorial Sloan Kettering Cancer Center

Publications: 28

Nathanael S. Gray

Nathanael S. Gray

Stanford University

Publications: 27

Mary-Ellen Taplin

Mary-Ellen Taplin

Harvard University

Publications: 27

Arturo Molina

Arturo Molina

Sutro Biopharma

Publications: 26

Larry H. Matherly

Larry H. Matherly

Wayne State University

Publications: 25

Peter S. Nelson

Peter S. Nelson

Fred Hutchinson Cancer Research Center

Publications: 25

Stan B. Kaye

Stan B. Kaye

Royal Marsden NHS Foundation Trust

Publications: 25

Trending Scientists

Elena V. Shevchenko

Elena V. Shevchenko

Argonne National Laboratory

Eileen E. M. Furlong

Eileen E. M. Furlong

European Bioinformatics Institute

Margareta Mikkelsen

Margareta Mikkelsen

Kennedy Center

Axel Mecklinger

Axel Mecklinger

Saarland University

Nancy L. Galambos

Nancy L. Galambos

University of Alberta

Farida Sohrabji

Farida Sohrabji

Texas A&M University

Guangheng Dong

Guangheng Dong

Zhejiang Normal University

Trevor L. Wang

Trevor L. Wang

John Innes Centre

Maen M. Husein

Maen M. Husein

University of Calgary

Sanglu Lu

Sanglu Lu

Nanjing University

Merlin L. Bruening

Merlin L. Bruening

University of Notre Dame

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Maria Tsokos

Maria Tsokos

Beth Israel Deaconess Medical Center

Fabrizio Durante

Fabrizio Durante

University of Salento

Vijay Gupta

Vijay Gupta

Netaji Subhas University of Technology

Timothy Connallon

Timothy Connallon

Monash University

Related Molecular Biology Rankings & Guides

2027 How to Become a Licensed Pharmacist in Dallas, TX: License Requirements

2027 How to Become a Licensed Pharmacist in Dallas, TX: License Requirements
2027 Certified Nurse Aide (CNA) License Education Requirements in South Carolina

2027 Certified Nurse Aide (CNA) License Education Requirements in South Carolina
2027 How to Become a Medical Biller & Coder in Tennessee

2027 How to Become a Medical Biller & Coder in Tennessee
2027 Do You Need a Doctorate (DNP) Degree to be a Nurse Practitioner?

2027 Do You Need a Doctorate (DNP) Degree to be a Nurse Practitioner?
2027 How to Become a Caregiver: Certification Requirements in Oregon

2027 How to Become a Caregiver: Certification Requirements in Oregon
2027 How to Become a Caregiver: Certification Requirements in Alabama

2027 How to Become a Caregiver: Certification Requirements in Alabama
2027 How To Become a Community Health Worker: Salary & Career Paths

2027 How To Become a Community Health Worker: Salary & Career Paths
2027 Highest Paying Medical Jobs with Little Schooling: 2-year Degrees That Pay Well

2027 Highest Paying Medical Jobs with Little Schooling: 2-year Degrees That Pay Well
2027 Hawaii Nursing License Requirements

2027 Hawaii Nursing License Requirements
2027 How to Become a Hospital CEO: Salary & Career Paths

2027 How to Become a Hospital CEO: Salary & Career Paths
2027 Benefits and Challenges of Becoming a Family Nurse Practitioner (FNP): What You Need to Know

2027 Benefits and Challenges of Becoming a Family Nurse Practitioner (FNP): What You Need to Know
2027 How to Become a Medical Assistant in Kentucky Online

2027 How to Become a Medical Assistant in Kentucky Online
2027 How to Become a Laboratory Technician – Salary & Requirements

2027 How to Become a Laboratory Technician – Salary & Requirements
2027 How to Become a Caregiver: Certification Requirements in Missouri

2027 How to Become a Caregiver: Certification Requirements in Missouri
2027 Hospice Nurse Salary by State

2027 Hospice Nurse Salary by State
2027 Easiest Types of Doctor to Become & How to Get There

2027 Easiest Types of Doctor to Become & How to Get There
2027 How to Become a Holistic Nurse Practitioner

2027 How to Become a Holistic Nurse Practitioner
2027 How to Become a Medical Biller & Coder in Massachusetts

2027 How to Become a Medical Biller & Coder in Massachusetts
2027 Best Non-Clinical Healthcare Jobs & Careers You Should Consider

2027 Best Non-Clinical Healthcare Jobs & Careers You Should Consider
2027 How to Become a Caregiver: Certification Requirements in Louisiana

2027 How to Become a Caregiver: Certification Requirements in Louisiana
2027 Average Neonatal Nurse Salary by State: How Much Do Neonatal Nurses Make?

2027 Average Neonatal Nurse Salary by State: How Much Do Neonatal Nurses Make?

Recently Published Articles

2027 Fastest Accredited Online Hospitality Management Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online Hospitality Management Programs: Accelerated Degrees and Completion Times
2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply

2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply
2027 Online Applied Psychology Master's Degree Program Costs: Tuition & Fees

2027 Online Applied Psychology Master's Degree Program Costs: Tuition & Fees
2027 Licensed Master Social Worker (LMSW) vs Licensed Clinical Social Worker (LCSW)

2027 Licensed Master Social Worker (LMSW) vs Licensed Clinical Social Worker (LCSW)
2027 Best Online Data Science Degree Master's Programs for Working Professionals

2027 Best Online Data Science Degree Master's Programs for Working Professionals
2027 Online Computer Science Degree Master's Programs That Accept FAFSA

2027 Online Computer Science Degree Master's Programs That Accept FAFSA
2027 How to Become a Pathologist: Education, Salary, and Job Outlook

2027 How to Become a Pathologist: Education, Salary, and Job Outlook
2027 Is a 2-Year Fine Arts Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs

2027 Is a 2-Year Fine Arts Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs
2027 Best Online Psychology Degree Programs

2027 Best Online Psychology Degree Programs
2027 Psychiatric Mental Health Nurse Practitioner Degree Programs That Accept Transfer Credits

2027 Psychiatric Mental Health Nurse Practitioner Degree Programs That Accept Transfer Credits
2027 ESL Teacher Requirements & ESOL Certification in New York

2027 ESL Teacher Requirements & ESOL Certification in New York
2027 Organizational Leadership Degree Programs With No GRE or GMAT Requirements

2027 Organizational Leadership Degree Programs With No GRE or GMAT Requirements
2027 How to Become a Speech Language Pathologist in Missouri: Requirements & Certification

2027 How to Become a Speech Language Pathologist in Missouri: Requirements & Certification
2027 Leadership vs. Management in Nursing: Which Path Should You Pursue?

2027 Leadership vs. Management in Nursing: Which Path Should You Pursue?
2027 Online School Psychology Degree Master's Programs That Accept FAFSA

2027 Online School Psychology Degree Master's Programs That Accept FAFSA
2027 Fastest Online Electrical Engineering Bachelor's Degree Programs You Can Finish in 3 Years or Less

2027 Fastest Online Electrical Engineering Bachelor's Degree Programs You Can Finish in 3 Years or Less
2027 Fastest Online Early Childhood Education Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Early Childhood Education Master's Degree Programs You Can Finish in Under 2 Years
2027 LPC Counseling Licensure Requirements in Texas

2027 LPC Counseling Licensure Requirements in Texas
2027 Cheapest and Shortest Online Health Administration Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Health Administration Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Best Online ABET-Accredited Engineering Degree Programs

2027 Best Online ABET-Accredited Engineering Degree Programs
2027 Digital Audiences Degrees Explained: Are They Classified as Professional Degrees?

2027 Digital Audiences Degrees Explained: Are They Classified as Professional Degrees?